Diagnosis and Treatment of Polycystic Ovary Syndrome


Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.


    Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

    February 27-28, 2025

    10th Annual Pediatric Congress

    Paris, France
    February 27-28, 2025

    4th World Congress on Women Health and Gynecology

    Paris, France
    April 24-25, 2025

    International Conference on Reproductive Health and Infertility

    Aix-en-Provence, France
    September 15-16, 2025

    8th International Conference on Probiotics and Prebiotics

    Vancouver, Canada

    Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in